Prilosec OTC was the first proton-pump inhibitor to cross over from prescription-only to over-the-counter, generating more than $130 million in first-year sales.
Prilosec OTC was the first proton-pump inhibitor to cross over from prescription-only to over-the-counter, generating more than $130 million in first-year sales.
Credit: 
3207DSN_OverTheCounter5-fig2.jpg